|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Hashibe M, Brennan P, Chuang SC, Boccia S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R,
Kelsey K, Koifman S, La Vecchia C, Lazarus P, Levi F, Lence JJ,
Mates D, Matos E, Menezes A, McClean MD, Muscat J, Eluf-Neto J,
Olshan AF, Purdue M, Rudnai P, Schwartz SM, Smith E, Sturgis EM,
Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Shangina O,
Pilarska A, Zhang ZF, Ferro G, Berthiller J and Boffetta P:
Interaction between tobacco and alcohol use and the risk of head
and neck cancer: pooled analysis in the international head and neck
cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev.
18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Gillison ML, Koch WM, Capone RB, Spafford
M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE,
Shah KV and Sidransky D: Evidence for a causal association between
human papillomavirus and a subset of head and neck cancers. J Natl
Cancer Inst. 92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Näsman A, Attner P, Hammarstedt L, Du J,
Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M,
Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H,
Munck-Wikland E and Dalianis T: Incidence of human papillomavirus
(HPV) positive tonsillar carcinoma in Stockholm, Sweden: an
epidemic of viral-induced carcinoma? Int J Cancer. 125:362–366.
2009.PubMed/NCBI
|
|
5.
|
Deng Z, Hasegawa M, Matayoshi S, Kiyuna A,
Yamashita Y, Maeda H and Suzuki M: Prevalence and clinical features
of human papillomavirus in head and neck squamous cell carcinoma in
Okinawa, southern Japan. Eur Arch Otorhinolaryngol. 268:1625–1631.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C,
Kim H, Axelrod R, Silverman CC, Redmond KP and Gillison ML: Human
papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ragin CC and Taioli E: Survival of
squamous cell carcinoma of the head and neck in relation to human
papillomavirus infection: review and meta-analysis. Int J Cancer.
121:1813–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Deng Z, Hasegawa M, Yamashita Y, Matayoshi
S, Kiyuna A, Agena S, Uehara T, Maeda H and Suzuki M: Prognostic
value of human papillomavirus and squamous cell carcinoma antigen
in head and neck squamous cell carcinoma. Cancer Sci.
103:2127–2134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Heath S, Willis V, Allan K, Purdie K,
Harwood C, Shields P, Simcock R, Williams T and Gilbert DC:
Clinically significant human papilloma virus in squamous cell
carcinoma of the head and neck in UK practice. Clin Oncol (R Coll
Radiol). 24:e18–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Smeets SJ, Hesselink AT, Speel EJ,
Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ,
Leemans CR and Brakenhoff RH: A novel algorithm for reliable
detection of human papillomavirus in paraffin embedded head and
neck cancer specimen. Int J Cancer. 121:2465–2472. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hoffmann M, Ihloff AS, Gorogh T, Weise JB,
Fazel A, Krams M, Rittgen W, Schwarz E and Kahn T: p16(INK4a)
overexpression predicts translational active human papillomavirus
infection in tonsillar cancer. Int J Cancer. 127:1595–1602. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lassen P, Eriksen JG, Hamilton-Dutoit S,
Tramm T, Alsner J and Overgaard J: Effect of HPV-associated
p16INK4Aexpression on response to radiotherapy and
survival in squamous cell carcinoma of the head and neck. J Clin
Oncol. 27:1992–1998. 2009.
|
|
14.
|
Klaes R, Friedrich T, Spitkovsky D, Ridder
R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel
Doeberitz M: Overexpression of p16(INK4A) as a specific marker for
dysplastic and neoplastic epithelial cells of the cervix uteri. Int
J Cancer. 92:276–284. 2001. View Article : Google Scholar
|
|
15.
|
Singhi AD and Westra WH: Comparison of
human papilloma-virus in situ hybridization and p16
immunohistochemistry in the detection of human
papillomavirus-associated head and neck cancer based on a
prospective clinical experience. Cancer. 116:2166–2173. 2010.
|
|
16.
|
Schache AG, Liloglou T, Risk JM, Jones TM,
Ma XJ, Wang H, Bui S, Luo Y, Sloan P, Shaw RJ and Robinson M:
Validation of a novel diagnostic standard in HPV-positive
oropharyngeal squamous cell carcinoma. Br J Cancer. 108:1332–1339.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bussu F, Sali M, Gallus R, Vellone VG,
Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R,
Graziani C, Micciche F, Almadori G, Galli J, Delogu G, Sanguinetti
M, Rindi G, Valentini V and Paludetti G: HPV infection in squamous
cell carcinomas arising from different mucosal sites of the head
and neck region. Is p16 immunohistochemistry a reliable surrogate
marker? Br J Cancer. 108:1157–1162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Fischer CA, Zlobec I, Green E, Probst S,
Storck C, Lugli A, Tornillo L, Wolfensberger M and Terracciano LM:
Is the improved prognosis of p16 positive oropharyngeal squamous
cell carcinoma dependent of the treatment modality? Int J Cancer.
126:1256–1262. 2010.
|
|
19.
|
Klingenberg B, Hafkamp HC, Haesevoets A,
Manni JJ, Slootweg PJ, Weissenborn SJ, Klussmann JP and Speel EJ:
p16 INK4A overexpression is frequently detected in tumour-free
tonsil tissue without association with HPV. Histopathology.
56:957–967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Saiki RK, Scharf S, Faloona F, Mullis KB,
Horn GT, Erlich HA and Arnheim N: Enzymatic amplification of
beta-globin genomic sequences and restriction site analysis for
diagnosis of sickle cell anemia. Science. 230:1350–1354. 1985.
View Article : Google Scholar
|
|
21.
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5
and GP6 elongated at their 3’ ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995.
|
|
22.
|
Manos MM, Ting Y, Wright DK, Lewis AJ,
Broker TR and Wolinsky SM: Use of polymerase chain reaction
amplification for the detection of genital human papillomaviruses.
Cancer Cells. 7:209–214. 1989.
|
|
23.
|
Remmerbach TW, Brinckmann UG, Hemprich A,
Chekol M, Kuhndel K and Liebert UG: PCR detection of human
papilloma-virus of the mucosa: comparison between MY09/11 and
GP5+/6+primer sets. J Clin Virol. 30:302–308.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wiest T, Schwarz E, Enders C,
Flechtenmacher C and Bosch FX: Involvement of intact HPV16 E6/E7
gene expression in head and neck cancers with unaltered p53 status
and perturbed pRb cell cycle control. Oncogene. 21:1510–1517. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Landis JR and Koch GG: The measurement of
observer agreement for categorical data. Biometrics. 33:159–174.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Viera AJ and Garrett JM: Understanding
interobserver agreement: the kappa statistic. Fam Med. 37:360–363.
2005.PubMed/NCBI
|
|
27.
|
Bland JM and Altman DG: Statistical
methods for assessing agreement between two methods of clinical
measurement. Lancet. 1:307–310. 1986. View Article : Google Scholar
|
|
28.
|
Charfi L, Jouffroy T, de Cremoux P, Le
Peltier N, Thioux M, Freneaux P, Point D, Girod A, Rodriguez J and
Sastre-Garau X: Two types of squamous cell carcinoma of the
palatine tonsil characterized by distinct etiology, molecular
features and outcome. Cancer Lett. 260:72–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Hafkamp HC, Manni JJ, Haesevoets A, Voogd
AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC and Speel EJ:
Marked differences in survival rate between smokers and nonsmokers
with HPV 16-associated tonsillar carcinomas. Int J Cancer.
122:2656–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Hannisdal K, Schjolberg A, De Angelis PM,
Boysen M and Clausen OP: Human papillomavirus (HPV)-positive
tonsillar carcinomas are frequent and have a favourable prognosis
in males in Norway. Acta Otolaryngol. 130:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Klussmann JP, Mooren JJ, Lehnen M,
Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I,
Preuss SF, Straetmans JM, Manni JJ, Hopman AH and Speel EJ: Genetic
signatures of HPV-related and unrelated oropharyngeal carcinoma and
their prognostic implications. Clin Cancer Res. 15:1779–1786. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Schwartz SR, Yueh B, McDougall JK, Daling
JR and Schwartz SM: Human papillomavirus infection and survival in
oral squamous cell cancer: a population-based study. Otolaryngol
Head Neck Surg. 125:1–9. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Evans M, Newcombe R, Fiander A, Powell J,
Rolles M, Thavaraj S, Robinson M and Powell N: Human
papillomavirus-associated oropharyngeal cancer: an observational
study of diagnosis, prevalence and prognosis in a UK population.
BMC Cancer. 13:2202013. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Jung AC, Briolat J, Millon R, de Reynies
A, Rickman D, Thomas E, Abecassis J, Clavel C and Wasylyk B:
Biological and clinical relevance of transcriptionally active human
papillomavirus (HPV) infection in oropharynx squamous cell
carcinoma. Int J Cancer. 126:1882–1894. 2010.PubMed/NCBI
|
|
35.
|
Lindquist D, Romanitan M, Hammarstedt L,
Nasman A, Dahlstrand H, Lindholm J, Onelov L, Ramqvist T, Ye W,
Munck-Wikland E and Dalianis T: Human papillomavirus is a
favourable prognostic factor in tonsillar cancer and its oncogenic
role is supported by the expression of E6 and E7. Mol Oncol.
1:350–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Isayeva T, Li Y, Maswahu D and
Brandwein-Gensler M: Human papillomavirus in non-oropharyngeal head
and neck cancers: a systematic literature review. Head Neck Pathol.
6(Suppl 1): S104–S120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Wang SS, Trunk M, Schiffman M, Herrero R,
Sherman ME, Burk RD, Hildesheim A, Bratti MC, Wright T, Rodriguez
AC, Chen S, Reichert A, von Knebel Doeberitz C, Ridder R and von
Knebel Doeberitz M: Validation of p16INK4aas a marker of
oncogenic human papillomavirus infection in cervical biopsies from
a population-based cohort in Costa Rica. Cancer Epidemiol
Biomarkers Prev. 13:1355–1360. 2004.PubMed/NCBI
|
|
38.
|
Smith EM, Wang D, Kim Y, Rubenstein LM,
Lee JH, Haugen TH and Turek LP: p16INK4aexpression,
human papilloma virus, and survival in head and neck cancer. Oral
Oncol. 44:133–142. 2008.
|
|
39.
|
Thomas J and Primeaux T: Is p16
immunohistochemistry a more cost-effective method for
identification of human papilloma virus-associated head and neck
squamous cell carcinoma? Ann Diagn Pathol. 16:91–99. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Hoffmann M, Tribius S, Quabius ES, Henry
H, Pfannenschmidt S, Burkhardt C, Gorogh T, Halec G, Hoffmann AS,
Kahn T, Rocken C, Haag J, Waterboer T and Schmitt M: HPV DNA,
E6*I-mRNA expression and
p16INK4Aimmunohistochemistry in head and neck cancer -
how valid is p16INK4Aas surrogate marker? Cancer Lett.
323:88–96. 2012.
|
